LFS-1107 (10 mg/kg, Intraperitoneal injection,once a week) can ameliorate the symptoms of ENKTL in SNK6 cell xenograft mouse model[1].
| Animal Model: | SNK6 cell xenograft mouse model[1] |
| Dosage: | 10 mg/kg |
| Administration: | Intraperitoneal injection (i.p.), once a week |
| Result: | Extended mouse survival and Eliminated tumor cells. |
